An error occurred retrieving content to display, please try again.
Page not found (404)
Sorry - the page you requested could not be found.
Please choose a page from the navigation or try a website search above to find the information you need.
Toolkit
1 MRC Centre for Reproductive Health, University of Edinburgh, Edinburgh, UK
2 Birmingham Clinical Trials Unit, University of Birmingham, Birmingham, UK
3 Adcal H.R. Consultancy, ,
4 Division of Pathology, University of Edinburgh, Edinburgh, UK
5 Department of Mathematics, Statistics and Computer Science, University of Cantabria, , Spain
6 Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, UK
7 Department of Clinical Radiology, Royal Infirmary of Edinburgh, Edinburgh, UK
8 Simpson Centre for Reproductive Health, Royal Infirmary, Edinburgh, UK
9 Birmingham Women’s and Children’s Hospital, Birmingham, UK
10 Reproductive and Maternal Medicine, University of Glasgow, Glasgow, UK
11 Department of Women’s and Children’s Health, Institute of Life Course and Medical Sciences, University of Liverpool, Liverpool, UK
12 University of Aberdeen, Aberdeen, UK
13 University of Birmingham, Birmingham, UK
14 Nottingham Clinical Trials Unit, University of Nottingham, Nottingham, UK
* Corresponding author Email: hilary.critchley@ed.ac.uk
Disclosure of interests of authors
Full disclosure of interests: Completed ICMJE forms for all authors, including all related interests, are available in the toolkit on the NIHR Journals Library report publication page at https://doi.org/10.3310/FGLQ1687.
Primary conflicts of interest: L.H.R. Whitaker receives grant funding from NIHR (NIHR129801). A.R.W. Williams has received consultancy fees (divided with the University of Edinburgh) from Bayer AG. R.R. Chodankar has been supported as a Clinical Research Fellow by Bayer AG between April 2018 to February 2021. T.J. Clark has received honoraria from Bayer AG for attending one advisory board meeting (2015) and hands-on training of three clinicians in Essure sterilisation (made by Bayer; 2016) and from Gedeon Richter as part of the Orbis educational programme in Women’s Health (sponsored by GR since 2016) and for travel and accommodation expenses to attend FIGO in Rome (2012). He has been President of the British Society for Gynaecological Endoscopy (2019–22). He has been a member of the HTA Prioritisation Committee B (In hospital care; 2017–22) and HTA Prioritisation Committee C (mental health, women and children’s health; 2017–22). He has current research funding as the lead, or as a co-applicant, from the NIHR HTA Programme for the following research projects: NIHR130310, NIHR128991, NIHR127280, NIHR 129801. M.A. Lumsden has advised Gedeon Richter (2018). D.K. Hapangama receives grant funding from Wellbeing of Women (RG213), MRC (MR/V007238/1) and Northwest Cancer Research (RDG2021.18) as well as honoraria from Canadian Society of Fertility and Andrology. L. Saraswat reports grants from NIHR for conduct of trial (NIHR127280; 2019) and receiving honorarium from Gideon-Richter for attending one advisory board meeting (2022). S. Bhattacharya receives royalties from Cambridge University Press and payment (to University of Aberdeen) for speaking at 11th Singapore International Congress on Obstetrics and Gynaecology, and invited lectures to Merck and Ferring. He is a board member of NHS Grampian for which the University of Aberdeen receives payment. He receives an honorarium from Oxford University Press for his role as Editor in Chief (Human Reproduction Open) is special Senior Editor, Cochrane Gynaecology and Infertility (no honorarium). P. Smith receives grant funding from an NIHR Fellowship (PDF-2015-08-099). J. Daniels is a member of NIHR CTU Standing Advisory Committee. H.O.D. Critchley has received grant funding (paid to institution) from the Biotechnology and Biological Sciences Research Council, grants from the Medical Research Council/NIHR to support salaries for research staff and study consumables and a research collaboration grant from Bayer AG, Berlin, with salaries for research staff and study consumables. She has personal receipt of royalties from ‘Up-To-Date’ for an article on abnormal uterine bleeding. She has received consulting fees paid to institution from Bayer AG (Consultancy and Scientific Advisory Board advice; no personal remuneration received), Gedeon Richter (Consultancy advice; no personal remuneration received) and Myovant Sciences GmbH (Consultancy and Scientific Advisory Board advice; no personal remuneration received). She has received speaker fees from Vifor Pharma UK Ltd (with no personal remuneration received) and travel expenses for attendance(s) at SAB (Scientific Advisory Board). She is Chair (from 2021–23) of the Committee for Menstrual Disorders and Related Health Impacts of the International Federation of Gynecology and Obstetrics (no payment received).
Funding: This project was funded by the National Institute for Health and Care Research (NIHR) Efficacy and Mechanism Evaluation Programme and will be published in full in Efficacy and Mechanism Evaluation Vol. 10, No. 8. See the NIHR Journals Library website for further project information.
Funding: {{metadata.Funding}}
{{metadata.Journal}} Volume: {{metadata.Volume}}, Issue: {{metadata.Issue}}, Published in {{metadata.PublicationDate | date:'MMMM yyyy'}}
https://doi.org/{{metadata.DOI}}
Citation: {{author}}{{ (($index < metadata.AuthorsArray.length-1) && ($index <=6)) ? ', ' : '' }}{{(metadata.AuthorsArray.length <= 6) ? '.' : '' }} {{(metadata.AuthorsArray.length > 6) ? 'et al.' : ''}} . {{metadata.JournalShortName}} {{metadata.PublicationDate | date:'yyyy'}};{{metadata.Volume}}({{metadata.Issue}})
Report Content
The full text of this issue is available as a PDF document from the Toolkit section on this page.
The full text of this issue is available as a PDF document from the Toolkit section on this page.
Responses to this report
No responses have been published.